EUVIMEDEUVIMED entdecken
Open Access

NLRP3 Inflammasome Activation in Peripheral Arterial Disease

Francesca Bartoli-Leonard iD, Jonas Zimmer iD, Abhijeet R Sonawane, Katelyn Perez, Mandy E Turner, Shiori Kuraoka, Tan Pham, Feifei Li, Masanori Aikawa iD, Sasha Singh iD, Luke Brewster, Elena Aikawa iD

Journal of the American Heart Association · 21.03.2023 · 12 (6)

DOI: 10.1161/jaha.122.026945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 21.03.2023. Verfasst von Francesca Bartoli-Leonard und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine, Center for Interdisciplinary Cardiovascular Sciences Brigham and Women's Hospital, Harva…. Hauptthemen laut MEDLINE: Inflammasomes, Peripheral Arterial Disease. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Peripheral arterial disease (PAD) is estimated to affect 7% of the adult population in the United States; however, there is currently little understanding of the key cellular and molecular pathways at play. With PAD characterized by vascular inflammation and associated calcification, the current study set out to elucidate the role of NLRP3 (nucleotide oligomerization domain‐like receptor family, pyrin domain containing 3) inflammasome activation in the current cohort. Methods and Results Global proteomics of human vessels with and without PAD from a total of 14 donors revealed an increase of proinflammatory associated ontologies, specifically acute phase and innate immunity. Targeted mass spectrometry showed a significant increase in NLRP3, confirmed by NLRP3 ELISA. Histological analysis from the same patients demonstrated expression of NLRP3, colocalizing in immunoreactive CD68 (cluster of differentiation 68) and CD209 (cluster of differentiation 209) macrophages. Moreover, transmission electron microscopy showed the locality of macrophage‐like cells in the presence of calcification, with confocal microscopy further validating the localization of CD68, NLRP3, and calcification via near‐infrared calcium tracer. Systemic inflammation and the presence of the NLRP3 inflammasome was assessed via flow cytometry and ELISA, respectively. Compared with patients without PAD, NLRP3 expression was significantly increased in serum. In addition, proinflammatory cytokine presence was significantly increased in disease versus control, with IL (interleukin)‐1β, TNF‐α (tumor necrosis factor α), and IL‐33 demonstrating the greatest disparity, correlating with NLRP3 activation.

Conclusions

The current findings demonstrate a link between NLRP3, macrophage accumulation, and calcification in arteries of patients with PAD, suggesting an association or possible driver of PAD in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammasomesPeripheral Arterial DiseaseAdultHumansInflammationInterleukin-1betaMacrophagesNLR Family, Pyrin Domain-Containing 3 ProteinTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

peripheralproteomicsvascular biologyvascular diseasevascular disease inflammation

Substanzen

InflammasomesInterleukin-1betaNLR Family, Pyrin Domain-Containing 3 ProteinTumor Necrosis Factor-alphaNLRP3 protein, human

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Medicine, Center for Interdisciplinary Cardiovascular Sciences Brigham and Women's Hospital, Harvard Medical School Boston MA USA.
  • Division of Cardiovascular Medicine, Department of Medicine, Center for Excellence in Vascular Biology Brigham and Women's Hospital, Harvard Medical School Boston MA USA.
  • Department of Surgery Emory University School of Medicine Atlanta GA USA.
  • Surgical and Research Services Atlanta, Veterans Association Medical Centre GA Decatur USA.

ORCID-Profile: Francesca Bartoli-Leonard, Jonas Zimmer, Masanori Aikawa, Sasha Singh, Elena Aikawa

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Bartoli-Leonard, F., Zimmer, J., Sonawane, A. R., Perez, K., Turner, M. E., Kuraoka, S., Pham, T., Li, F., Aikawa, M., Singh, S., Brewster, L., & Aikawa, E. (2023). NLRP3 Inflammasome Activation in Peripheral Arterial Disease. Journal of the American Heart Association, 12(6). https://doi.org/10.1161/jaha.122.026945

Vancouver

Bartoli-Leonard F, Zimmer J, Sonawane AR, Perez K, Turner ME, Kuraoka S, et al. NLRP3 Inflammasome Activation in Peripheral Arterial Disease. Journal of the American Heart Association. 2023;12(6). doi:10.1161/jaha.122.026945

BibTeX
@article{BartoliLeonard2023,
  author = {Bartoli-Leonard, Francesca and Zimmer, Jonas and Sonawane, Abhijeet R and Perez, Katelyn and Turner, Mandy E and Kuraoka, Shiori and Pham, Tan and Li, Feifei and Aikawa, Masanori and Singh, Sasha and Brewster, Luke and Aikawa, Elena},
  title = {NLRP3 Inflammasome Activation in Peripheral Arterial Disease},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {6},
  doi = {10.1161/jaha.122.026945}
}
Kostenlos starten →